544611 — Mahamaya Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹3.45bn
- IN₹4.09bn
- IN₹2.64bn
- 42
- 36
- 77
- 52
Annual cashflow statement for Mahamaya Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 39 | 37.2 | 51 | 74.3 | 173 |
| Depreciation | |||||
| Non-Cash Items | 6.83 | 18.6 | 33.9 | 56.2 | 65.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 55.8 | -43.8 | -86.3 | -379 | -289 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 107 | 21.6 | 11.2 | -235 | -33.1 |
| Capital Expenditures | -80.6 | -32.7 | -28.9 | -15.1 | -50.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.21 | 0.154 | 0.428 | 1.34 | 5.69 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -76.4 | -32.5 | -28.5 | -13.8 | -44.8 |
| Financing Cash Flow Items | -10.4 | -16.3 | -28.5 | -57.2 | -87.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -37 | 13.8 | 23.6 | 245 | 84.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.38 | 2.86 | 6.28 | -3.12 | 6.86 |